ORAI1, ORAI calcium release-activated calcium modulator 1, 84876
N. diseases: 195; N. variants: 14
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 12 | 121627018 | missense variant | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2005 | 2006 | ||||||||
|
0.851 | 0.320 | 12 | 121641471 | missense variant | C/T | snv |
|
0.800 | 1.000 | 2 | 2014 | 2017 | |||||||||
|
1.000 | 12 | 121627039 | missense variant | G/A;C | snv | 4.2E-06 |
|
0.800 | 1.000 | 2 | 2014 | 2017 | |||||||||
|
1.000 | 0.040 | 12 | 121641369 | missense variant | C/A | snv | 2.0E-05 | 2.1E-05 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
|
1.000 | 0.120 | 12 | 121626888 | frameshift variant | -/CCGCCGCCGCAGCGGGGACGGGGAGCCCCCGGGGGCC | ins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 12 | 121627037 | missense variant | C/G | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.120 | 12 | 121641318 | missense variant | T/C | snv | 3.2E-05 | 3.5E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 0 | |||||||||
|
1.000 | 12 | 121641149 | missense variant | C/T | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 0.120 | 12 | 121641045 | missense variant | C/A | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 0.120 | 12 | 121627005 | frameshift variant | -/A | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 0 | |||||||||||
|
0.925 | 0.120 | 12 | 121627018 | missense variant | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||||
|
0.882 | 0.160 | 12 | 121625105 | upstream gene variant | T/C | snv | 0.23 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.160 | 12 | 121625105 | upstream gene variant | T/C | snv | 0.23 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 12 | 121625105 | upstream gene variant | T/C | snv | 0.23 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.160 | 12 | 121625105 | upstream gene variant | T/C | snv | 0.23 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.320 | 12 | 121641471 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.851 | 0.320 | 12 | 121641471 | missense variant | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Nervous System Diseases; Mental Disorders; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.851 | 0.320 | 12 | 121641471 | missense variant | C/T | snv |
|
Musculoskeletal Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.120 | 12 | 121638011 | intron variant | T/C | snv | 0.26 |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.120 | 12 | 121638011 | intron variant | T/C | snv | 0.26 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.120 | 12 | 121641762 | 3 prime UTR variant | A/G | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.882 | 0.120 | 12 | 121641762 | 3 prime UTR variant | A/G | snv | 0.36 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.120 | 12 | 121641762 | 3 prime UTR variant | A/G | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.240 | 12 | 121631099 | intron variant | T/C;G | snv |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.827 | 0.240 | 12 | 121631099 | intron variant | T/C;G | snv |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 |